| Date | Subject |
|---|---|
| 2022-09-11 21:33:51 | Good morning! #premarket #watchlist 09/12 $VTYX -had its price objective lifted by equities researchers at Oppenheimer from $40.00 to $65.00, $SPPI -Announces Data from Poster Presentation for Poziotinib, $CLVS -Clovis Oncology s Rubraca (Rucaparib) as First-Line Maintenance Treatment Improve |
